American Society of Clinical Oncology (ASCO)

The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield, Harry Bisel, Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright, it has nearly 45,000 members worldwide.

Pharmacokinetics of MEDI4736, an Anti-PD-L1 Monoclonal Antibody, in Advanced Solid Tumors

ASCO 2014 – Immuno-Oncology

Immuno-Oncology: The New Frontier?

ASCO 2014 – Immuno-Oncology

Ipilimumab Combined with Cytotoxic Chemotherapy in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology

Doublets and Triple Combinations in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology

Stereotactic Radiosurgery and Ipilimumab for Melanoma Brain Metastases

ASCO 2014 – Immuno-Oncology

Peginterferon alfa-2b Combined with Ipilimumab for Advanced Melanoma

ASCO 2014 – Immuno-Oncology

Single-Agent Nivolumab in Advanced NSCLC

ASCO 2014 – Immuno-Oncology

Nivolumab Combined with Platinum-Based Doublet Chemotherapy in Advanced NSCLC

ASCO 2014 – Immuno-Oncology

Gefitinib Plus Carboplatin/Pemetrexed as First-Line Therapy of EGFR+ NSCLC

ASCO 2014 – Lung Cancer

First-Line Nivolumab Monotherapy in Advanced NSCLC

ASCO 2014 – Lung Cancer

Page 27 of 33

24
25
26
27
28
29
30

Conference Coverage Proudly Presented by

American Health & Drug Benefits

Journal of Hematology Oncology Pharmacy

Journal of Oncology Navigation & Survivorship

Oncology Practice Management

Personalized Medicine in Oncology

The Oncology Nurse–APN/PA

The Oncology Pharmacist

Value-Based Cancer Care

Learn more about our family of publications.

View Our Publications